Vision and Access

Blindness reflected institutions as well as pathology

Bath observed that Black patients at Harlem Hospital experienced far more blindness than patients she encountered at Columbia. The comparison directed attention toward delayed diagnosis and unequal access rather than presumed racial biology.

Community ophthalmology moved care outward

Bath promoted programmes combining ophthalmology with public health and community medicine. Screening could identify glaucoma, cataract, and other problems before irreversible loss, but only when referral and affordable treatment followed.

She restored surgical services

Harlem Hospital's eye clinic lacked eye surgery when Bath trained there. She helped bring operative services to the institution, demonstrating that disparities were produced by resource allocation within medicine.

The Laserphaco work pursued a technical solution

Bath developed and patented devices using laser energy in cataract treatment. Her work belonged within a broad, evolving history of cataract extraction, lens implantation, ultrasound phacoemulsification, lasers, and microsurgical instruments rather than replacing all other methods.

Prevention became an organisational mission

In 1976 she co-founded the American Institute for the Prevention of Blindness, promoting the principle that sight is a basic human right. Outreach and technology were connected through the goal of making effective care reachable.

Training and Barriers

Professional firsts marked structures that remained unequal

Raised in Harlem, Bath studied chemistry at Hunter College and medicine at Howard University. She interned at Harlem Hospital and became the first Black resident in ophthalmology at New York University.

At UCLA she entered academic ophthalmology, corneal surgery, and training leadership while confronting sexism and racism. Laboratory space, promotion, patents, and recognition were not distributed independently of identity.

Bath became the first Black woman physician known to receive a United States medical patent. The milestone matters because patent systems shape ownership and credibility, though invention still depends on engineers, technicians, manufacturers, clinicians, and patients.

Legacy

Innovation includes deciding which problem deserves resources

Bath's history is sometimes reduced to the Laserphaco Probe. Her wider contribution began with an epidemiological and moral observation: avoidable blindness was concentrated where routine eye care was weakest.

That framing remains important. A technically curable cataract can still cause blindness when screening, trained staff, operating facilities, follow-up, or money are unavailable. Community ophthalmology made distribution part of medical effectiveness.

Across the collection

Continue from Bath

Public health

Connect population evidence to prevention and service distribution.

North America

Place medical technology within segregated and unequal institutions.